LuisZeichner(Ostrosky-Zeichner)OstroskyMDFACP, FIDSA, FSHEA, FECMM
Infectious Disease • Houston, TXHealthcare Associated Infections, Transplant/Immunocompromised States
Professor and chief, Memorial Hermann Endowed Chair, Division of Infectious Diseases, University of Texas Medical School at Houston
Dr. Ostrosky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6431Fannin St
MSB 2112.F
Houston, TX 77030Phone+1 713-500-6733Fax+1 713-500-5495
Summary
- Professor of medicine and epidemiology, Memorial Hermann Endowed Chair, Vice-Chair of Medicine, Director, Laboratory of Mycology Research, Division Chief, Infectious Diseases, UTHealth. Chief Epidemiology Officer, Memorial Hermann. Senior Editor, Journal of Antimicrobial Chemotherapy. Assoc. Editor, Clinical Infectious Diseases. Past-President of the Mycoses Study Group. Consultant, FDA and CDC.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 1999 - 2002
U Texas Med Sch1999 - 2002
Universidad Nacional Autonoma de MexicoClass of 1995, Honors
Certifications & Licensure
TX State Medical License 2002 - 2026- American Board of Medical QualityCMQ
Awards, Honors, & Recognition
- Fellow European Confederation of Medical Mycology
- Fellow American College of Physicians
- Fellow Infectious Diseases Society of America
- Join now to see all
Clinical Trials
- Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) Start of enrollment: 2007 Aug 01
- Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment Start of enrollment: 2017 Apr 01
- CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients Start of enrollment: 2020 Apr 17
Publications & Presentations
PubMed
- 9 citationsOutpatient Infection Prevention: A Practical PrimerFozia Steinkuller, Kristofer Harris, Karen J. Vigil, Luis Ostrosky-Zeichner
Open Forum Infectious Diseases. 2018-05-01 - 439 citationsInvasive candidiasis.Peter G Pappas, Michail S Lionakis, Maiken Cavling Arendrup, Luis Ostrosky-Zeichner, Bart Jan Kullberg
Nature Reviews. Disease Primers. 2018-05-11 - 1444 citationsRevision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study G...J. Peter Donnelly, Sharon C.-A. Chen, Carol A. Kauffman, William J. Steinbach, John W. Baddley
Clinical Infectious Diseases. 2020-09-12
Authored Content
- IDWeek 2018: Accuracy of the NHSN Central Line-Associated Bloodstream Infection DefinitionOctober 2018
- IDWeek 2018: Accuracy of the NHSN Central Line-Associated Bloodstream Infection DefinitionOctober 2018
- IDWeek 2018: Using Blockchain to Develop a Novel Propensity Score for Candidemia and Invasive CandidiasisOctober 2018
Press Mentions
Texas Has One of the Lowest Vaccination Rates in the U.S. Here's WhySeptember 19th, 2024- Do Expired COVID Tests Still Work?September 6th, 2024
- Sloth Fever Is in the U.S. — Texas Disease Specialist Explains What to KnowAugust 31st, 2024
- Join now to see all
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
